Lipid Nanoparticle Peptide Targeting for Brain Lesion CsA Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for traumatic brain injury (TBI) are limited by the poor water solubility and high binding rate of cyclosporine A (CsA) to plasma proteins, making it difficult to cross the blood-brain barrier, and high doses lead to systemic side effects, limiting its clinical application.
Innovation Solution
A lipid nano drug delivery system is developed, incorporating a functional penetrating peptide to target brain lesions, using a dilution-induced precipitation method to encapsulate cyclosporine A, which includes a peptide sequence designed to enhance brain targeting and mitigate side effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cyclosporine A is administered orally at high doses to achieve neuroprotective effect, then the neuroprotective effect is improved, but systemic side effects (immunosuppression, hepatotoxicity, nephrotoxicity) increase
Solution Approach 1:
The patent segments the drug delivery system into multiple functional components: a lipid nanoparticle core for drug encapsulation, a PEGylated layer for stealth properties and circulation stability, and a targeting ligand layer for brain-specific delivery. This segmentation allows the drug to be delivered precisely to the brain while minimizing systemic exposure and side effects
Solution Approach 2:
The lipid nanoparticle acts as an intermediary carrier that solves the dual problem of poor water solubility and high plasma protein binding of cyclosporine A. The nanoparticle encapsulates the hydrophobic drug, provides a hydrophilic surface for circulation, and incorporates targeting ligands for brain penetration, thereby mediating between the drug's limitations and the desired therapeutic outcome
2Reliability
If cyclosporine A is administered to cross the blood-brain barrier, then brain penetration is improved, but water solubility and plasma protein binding limitations worsen drug delivery
Solution Approach 1:
The patent changes the physical and chemical parameters of the drug delivery system by forming a nanoparticle with specific size (20-200 nm), surface charge (positive zeta potential), and composition (lipid ratio, PEGylation degree). These parameter optimizations enhance brain penetration while overcoming solubility and protein binding limitations
Solution Approach 2:
The patent creates a composite nanoparticle system combining hydrophobic lipids for drug encapsulation, hydrophilic PEG for circulation stability, and cationic targeting ligands for blood-brain barrier penetration. This composite structure simultaneously addresses multiple delivery challenges that cannot be solved by a single material
3Reliability
If a lipid nano drug delivery system with functional penetrating peptide is used, then targeted delivery to brain lesion is improved, but system complexity increases
Solution Approach 1:
The functional penetrating peptide is designed to perform multiple functions simultaneously: it provides cationic charge for blood-brain barrier penetration, contains MMP-9 sensitive sequences for lesion-specific activation, and offers polyanion inhibitory sequences for enhanced stability. This multi-functionality reduces the need for separate components, thereby managing complexity while achieving targeted delivery
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system effectively delivers cyclosporine A to brain lesions, repairing mitochondria with a small administration dose, reducing side effects and improving neurological function.
Implementation Method 1
The mitochondria are repaired by encapsulating peptide drug cyclosporin A with a lipid nanoparticle core by a dilution-induced precipitation
Implementation Method 2
an arginine-rich penetrating peptide
Implementation Method 3
a matrix metalloproteinase-9 sensitive peptide
Data Source
AI summary
A lipid nano drug delivery system targeting a brain lesion and a preparation method and application thereof. The drug delivery system comprises a lipid, a delivery drug, and a functional penetrating peptide, and the functional penetrating peptide is formed by covalently connecting a peptide chain linking a nanocarrier end, an arginine-rich penetrating peptide, a matrix metalloproteinase-9 sensitive peptide, and a polyanion inhibitory peptide. The lipid nano drug delivery system can be used for targeting the brain lesion and realizing mitochondrial enrichment by means of modification of the functional penetrating peptide. The repair of mitochondria is realized by encapsulating peptide drug cyclosporin A by means of a lipid nanoparticle core by utilizing a dilution-induced precipitation technique, thereby solving the problems that current cyclosporin A is difficult to effectively reach a brain lesion and the therapeutic window is small, and improving the ability to repair cells around the brain lesion with a small administration dose.